Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta

C-K Joo1, H-S Kim, J-Y Park

  • 1Laboratory of Visual Science, Korea Eye Tissue and Gene Bank, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Oncogene
|July 20, 2007
PubMed

Insights

Transforming growth factor-beta (TGF-beta) activates epidermal growth factor receptor (EGFR) independently of Smad proteins. This novel pathway involves Src family kinases, reactive oxygen species, and E-cadherin, diversifying TGF-beta signaling.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Cancer research

Background:

  • Transforming growth factor-beta (TGF-beta) elicits diverse cellular responses.
  • While Smad proteins mediate many TGF-beta signals, non-Smad pathways are increasingly recognized.
  • Understanding alternative TGF-beta signaling mechanisms is crucial for deciphering complex cellular processes.

Purpose of the Study:

  • To investigate the non-Smad signaling pathways activated by TGF-beta1.
  • To determine the role of epidermal growth factor receptor (EGFR) transactivation in TGF-beta1 signaling.
  • To elucidate the upstream regulators and downstream effectors of EGFR transactivation by TGF-beta1.

Main Methods:

  • Immunoprecipitation and immunofluorescence staining to detect EGFR phosphorylation.
  • Cell-based assays to assess the roles of Src family kinases (SFKs), reactive oxygen species (ROS), and E-cadherin.
  • Gene expression analysis of c-Fos and c-Jun.
  • Stable cell line transfection and blocking assays.

Main Results:

  • TGF-beta1 induces EGFR transactivation, evidenced by tyrosine phosphorylation.
  • EGFR transactivation is dependent on SFKs and ROS generation via NADPH oxidase, but not metalloproteases or EGF-like ligand release.
  • ROS production requires SFK signaling and de novo protein synthesis.
  • E-cadherin-mediated cell-cell interactions are essential for EGFR transactivation.
  • EGFR transactivation regulates c-Fos and c-Jun expression through the extracellular signal-regulated kinase (ERK) pathway.

Conclusions:

  • TGF-beta1 can activate EGFR independently of Smad proteins and ligand release.
  • This non-Smad pathway, involving SFKs, ROS, and E-cadherin, diversifies TGF-beta signaling.
  • EGFR transactivation represents a novel mechanism for TGF-beta-mediated gene expression, potentially impacting cellular behavior and disease.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...